CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
OPERATING ACTIVITIES:
Net income (loss)	$ 75,574	$ 20,567	$ (60,591)
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
Depreciation	19,998	18,964	24,372
Amortization, including accretion of deferred financing costs	3,615	3,833	5,709
Deferred income taxes	(38,747)	(2,165)	(3,238)
Earnings of equity method investee	(1,233)	(608)	(815)
Loss on sale of fixed assets	48	74	110
Share-based compensation expense	6,134	7,224	5,406
Tax benefits related to share-based compensation expense	(977)
Goodwill impairment charge (benefit)			51,458
Loss on disposal of business		210	8,576
Loss on early extinguishment of debt			10,607
Changes in operating assets and liabilities
Accounts receivable, net	(18,694)	(489)	(19,400)
Inventories, net	4,519	(4,340)	3,161
Prepaid expenses and other assets	2,652	(295)	(1,306)
Accounts payable	10,980	6,577	524
Accrued expenses and other liabilities	1,408	5,253	(4,758)
Net cash provided by operating activities	65,277	54,805	19,815
INVESTING ACTIVITIES:
Capital expenditures	(24,476)	(28,735)	(24,754)
Proceeds from sale of fixed assets	652	64	110
Payments related to sale of business		(1,230)
Proceeds from sale of business			71,386
Business acquisition		(469)	(1,022)
Net cash provided by (used for) investing activities	(23,824)	(30,370)	45,720
FINANCING ACTIVITIES:
Revolving credit facility borrowings			100,000
Revolving credit facility payments	(33,000)
Extinguishment of senior notes			(175,000)
Premium related to early extinguishment of senior notes			(8,006)
Proceeds from issuance of other debt	16,223	22,540	30,072
Repayments of debt	(25,748)	(30,586)	(25,610)
Noncontrolling interest shareholder distribution			(1,083)
Other financing costs	(399)	(49)	(1,666)
Repurchase of Common Shares to satisfy employee tax withholding	(1,424)	(2,924)	(765)
Tax benefits related to share-based compensation expense	977
Net cash used for financing activities	(43,371)	(11,019)	(82,058)
Effect of exchange rate changes on cash and cash equivalents	(2,054)	(2,076)	(3,281)
Net change in cash and cash equivalents	(3,972)	11,340	(19,804)
Cash and cash equivalents at beginning of period	54,361	43,021	62,825
Cash and cash equivalents at end of period	50,389	54,361	43,021
Supplemental disclosure of cash flow information:
Cash paid for interest	5,786	6,092	20,464
Cash paid for income taxes, net	3,386	2,494	3,054
Supplemental disclosure of non-cash operating and financing activities:
Change in fair value of interest rate swap			(793)
Bank payment of vendor payables under short-term debt obligations	$ 3,764	$ 5,323	$ 4,758

The aggregate expense charged against earnings to allocate the cost of intangible assets including deferred financing costs (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Also included in this amount is the accretion of the debt discount and the deferred financing costs which are a component of interest expense representing the periodic charge against earnings to reflect amortization of debt discounts and deferred financing costs over the life of the related debt instrument. As a noncash expense, this element is added back to net income when calculating cash provided by (used in) operations using the indirect method.

No definition available.